Using early viral kinetics to predict antiviral outcome in response-guided pegylated interferon plus ribavirin therapy among patients with hepatitis C virus genotype 1

2013 ◽  
Vol 49 (4) ◽  
pp. 737-747 ◽  
Author(s):  
Tsugiko Oze ◽  
Naoki Hiramatsu ◽  
Takayuki Yakushijin ◽  
Masanori Miyazaki ◽  
Sadaharu Iio ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Viral Kinetics ◽  
Pegylated Interferon Plus Ribavirin ◽  
Early Viral Kinetics

scholarly journals Effectiveness of sofosbuvir/pegylated-interferon plus ribavirin in treatment of hepatitis C virus genotype 4 patients

2018 ◽  
Vol 4 (3) ◽  
pp. 191-196 ◽  
Author(s):  
Abel Abdel-Moneim ◽  
Alaa Abood ◽  
Mohamed Abdel-Gabaar ◽  
Mohamed I. Zanaty ◽  
Mohamed Ramadan
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Virus Genotype ◽  
Genotype 4 ◽  
Pegylated Interferon Plus Ribavirin

scholarly journals Long-term Pegylated Interferon Monotherapy Following 72 Weeks of Pegylated Interferon and Ribavirin in Hepatitis C Virus Genotype-1-infected Slow Responders

2015 ◽  
Vol 54 (3) ◽  
pp. 273-279 ◽  
Author(s):  
Shinya Watanabe ◽  
Yoshimasa Kobayashi ◽  
Kazuhito Kawata ◽  
Hidenao Noritake ◽  
Takeshi Chida ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Pegylated Interferon ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Interferon Monotherapy
Sign in / Sign up

Export Citation Format

Share Document